Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

The villain in this tale, is not the so-called “abortion ban.” It’s the Food and Drug Administration, the clinic, and the doctors.

With every major advancement in the field of aging biology, humankind is one step closer to turning back the clock and restoring our youth. In ...

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...

After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...

Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, ...

The Senate Judiciary Committee is scheduled to mark up two bipartisan bills Thursday that affordable-drug proponents and generics makers say would make it easier for major pharma companies to game the ...

The majority of FDA-recalled devices made it to market via the 510(k) pathway, which doesn’t require new clinical or safety ...

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has been informed by medac, licensor of Medexus’s commercialization rights ...

The U.S. Food and Drug Administration has approved the sleep apnea feature ... While the feature was announced, Apple ...

The unintended consequences of legislation are often as important as the original purpose. Two bills scheduled to be ...